Clinical and Endoscopic Improvement of Inflammatory Bowel Disease with Curcumin Therapy: Experiences from Clinical Studies

Authors

  • William Suciangto Faculty of Medicine, Hasanuddin University, Makassar
  • Munaiva Syahrir Department of Internal Medicine, Faculty of Medicine, Hasanuddin University

DOI:

https://doi.org/10.24871/2332022240-248

Keywords:

curcumin, inflammatory bowel disease, Crohn’s disease, ulcerative colitis

Abstract

Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, is a chronic inflammatory condition of the intestine and one of etiological factor for colon cancer development. Incidences of inflammatory bowel disease is still high around the world, even with current therapy, emerging the need for innovational approach to increase the achievement of disease improvement and remission. Curcumin is a natural compound derived from Curcuma longa and has been well known with its anti-inflammatory properties which is possible to be beneficial for inflammatory bowel disease. This review aims to provide clinical evidences of effectively and safety profile of curcumin in treating inflammatory bowel disease, both Crohn’s disease and ulcerative colitis, and viewing the future prospect of curcumin to be an effective adjuvant therapy to prevent the relapse of inflammatory bowel disease.

 

Downloads

Published

2022-12-26

How to Cite

Suciangto, W., & Syahrir, M. (2022). Clinical and Endoscopic Improvement of Inflammatory Bowel Disease with Curcumin Therapy: Experiences from Clinical Studies. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 23(3), 241–249. https://doi.org/10.24871/2332022240-248

Issue

Vol. 23 No. 3 (2022): VOLUME 23, NUMBER 3, December 2022

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).